BridGene Biosciences Announces $12 Million Series A Financing to Advance the Company's Proprietary Chemoproteomic Platform and Pipeline of Oncology Programs

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3h5qy1W
via IFTTT